Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-16, Stock:JNJ, The news for the past five days is as follows:
2019-10-09: NEWS1: Pharma Giant J&J Dips On $8 Billion Verdict Over Antipsychotic Drug.NEWS2: Johnson & Johnson -- Moody's: Risperdal verdict adds to J&J's litigation risk.NEWS3: Johnson & Johnson ordered to pay $8 billion in case tied to anti-psychotic drug.NEWS4: Top Trending: JNJ told to pay $8b to man over breast growth.NEWS5: US STOCKS-Tech stocks lift Wall St as reports brighten hopes of trade deal.NEWS6: JNJ Stock Gets A Boost After Settling Opioid Cases — But Should You Buy It?.NEWS7: Stocks - Wall Street Gains as Trade Tensions Ease a Little.NEWS8: J&J hit by "excessive" $8 bln verdict.NEWS9: J&J Ordered by Philadelphia Jury to Pay $8B in Risperdal Case.NEWS10: Johnson & Johnson hit with $8 billion trial verdict.NEWS11: Tech investors need to brace for this pivotal $160 billion ‘gut punch’ in December, says analyst Dan Ives.NEWS12: Apple, U.S. Steel, Johnson & Johnson, PG&E, Lions Gate: Companies to Watch.NEWS13: Dow Jones Jumps 150 Points On China News; Apple, Roku Rally On Analyst Actions.NEWS14: Dow Jones Today: Stocks Bounce As China Seeks Trade War Truce; Apple Gets Price Target Hike.NEWS15: Massive jury award against J&J highlights risks of its legal strategy.NEWS16: Stocks - J&J Tumbles Premarket; American Outdoor Brands, Exxon Mobil Rise.NEWS17: [video]Buy Johnson & Johnson Amid $8 Billion Verdict.NEWS18: US STOCKS-Wall St eyes strong open as reports fuel trade deal hopes.NEWS19: Johnson & Johnson Hit With $8B Verdict In Risperdal Lawsuit.NEWS20: Dow Jones Today: Futures Bounce As China Seeks Trade War Truce; Apple, Google Jump On 5G Rollout.NEWS21: Johnson & Johnson hit with $8B verdict over drug linked to boy growing breasts.NEWS22: FirstFT: Today’s top stories.NEWS23: [video]Dow Higher as China Signals Interest in Partial Trade Agreement.NEWS24: US STOCKS-Futures gain as reports fuel trade deal hopes.NEWS25: J&J Unit Ordered to Pay $8 Billion Over Anti-Psychotic Drug.NEWS26: Drugmakers in spotlight as GSK recalls Zantac.NEWS27: [video]Dow Climbs Ahead of Trade Talks as China Signals Interest in Partial Trade Pact.NEWS28: Stocks - Wall Street Opens Higher for First Time in Three Sessions.NEWS29: Johnson & Johnson Slides After $8 Billion Verdict in Pennsylvania Risperdal Case.NEWS30: China Trade Deal Optimism, J&J, Levi Strauss, PG&E - 5 Things You Must Know.NEWS31: Stocks - U.S. Futures Rise as China Offers to Buy American Agricultural Goods.NEWS32: Top 5 Things to Know in the Market on Wednesday.NEWS33: PRESS DIGEST- Wall Street Journal - Oct. 9.NEWS34: PRESS DIGEST- New York Times business news - Oct. 9.NEWS35: Johnson & Johnson hit with $8B verdict over drug linked to boy growing breasts.
2019-10-10: NEWS1: J&J (JNJ) to Start Q3 Earnings Season for Pharma Sector.NEWS2: Company News For Oct 10, 2019.
2019-10-11: NEWS1: Why Johnson & Johnson Stock Can Weather Legal Awards Against It.NEWS2: What to Expect from Q3 Earnings Season with Big Banks Set to Report?.NEWS3: J&J CEO touts Philadelphia's potential to be the 'Silicon Valley of health care'.NEWS4: Johnson & Johnson Stock Has Limited Upside.NEWS5: Pharma Stock Roundup: NVS' New Eye Drug Gets FDA Nod, NVO, GSK, PFE Sign Deals.NEWS6: Will Q3 Earnings Drive Dow ETF Higher?.NEWS7: J&J Rises After Analyst Calls Pharma Giant's Shares a Bargain.NEWS8: Geron Starts Enrollment in Phase III MDS Study on Imetelstat.NEWS9: The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout.
2019-10-14: NEWS1: Johnson & Johnson's (JNJ) Legal Problems Continue to Worry Investors.NEWS2: Dow Jones Futures: Tesla Reclaims Key Support; These 4 Dow Stocks Report Early Tuesday.NEWS3: J&J is swamped by opioid fears and lawsuits, but Wall Street isn't worried.NEWS4: Bank earnings — What to know in markets Tuesday.NEWS5: The Zacks Analyst Blog Highlights: Novartis, J&J, Pfizer, Novo Nordisk and Glaxo.NEWS6: Major Banks To Flood Wall Street with Earnings Data.NEWS7: Bank Holiday Ahead of Q3 Earnings, Trade Negotiations.NEWS8: Johnson & Johnson Is Reporting Its Earnings on Tuesday. Here’s What To Expect..
2019-10-15: NEWS1: Dow Jones Futures: 5 Big Movers Late; Stock Market Leader ASML On Tap With Earnings.NEWS2: US Indexes Close Higher Tuesday With 3rd-Quarter Earnings Kickoff.NEWS3: Oklahoma judge says he miscalculated award in J&J opioid case by $107 million.NEWS4: Wall Street Advances Tuesday.NEWS5: J&J Says No Legal Reserves Needed Amid Wave of Lawsuits.NEWS6: Drug Distributors Could Be Nearing An $18 Billion Opioid Settlement.NEWS7: Drug distributors in talks to settle opioid litigation for $18 bln - WSJ.NEWS8: Pharma Giant J&J Reports Rising Earnings, Sales — And Legal Fees.NEWS9: UPDATE 1-Missouri appeals court overturns $110 mln Johnson & Johnson talc verdict.NEWS10: JNJ, JP Morgan and UnitedHealth all Beat, Goldman Sachs Misses.NEWS11: Missouri appeals court overturns $110 million Johnson & Johnson talc verdict.NEWS12: PreMarket Prep Recap: Impressive Bank Earnings, Aphria Sparks Rally In Marijuana Sector.NEWS13: Jim Cramer: Here's What We Can Bask in Today.NEWS14: Johnson & Johnson (JNJ) Surpasses Q3 Earnings and Revenue Estimates.NEWS15: US STOCKS-Wall Street advances as earnings season hits the road running.NEWS16: Johnson & Johnson on mushrooming lawsuits: 'We're targets, unfortunately'.NEWS17: US STOCKS-Wall Street gains after strong start to earnings season.NEWS18: What Investors Need to Know About Johnson & Johnson's 3rd-Quarter Results.NEWS19: Johnson & Johnson Is Facing Mounting Legal Fees — Is JNJ Stock A Safe Buy?.NEWS20: Johnson & Johnson Stock Is Up After Its Earnings Beat.NEWS21: The Dow Is Up Because Strong Earnings Can Make Us Forget About Trade.NEWS22: Pharma Giant J&J Reports Rising Earnings, Sales — And Legal Fees.NEWS23: J&J (JNJ) Gets FDA Approval for Xarelto Label Expansion.NEWS24: J&J (JNJ) Beats on Q3 Earnings as Sales Rise, Ups 2019 View.NEWS25: Prescription drugs boost drives J&J forecasts higher, shares rise.NEWS26: Pharma Giant J&J Reports Rising Earnings, Sales — And Legal Fees.NEWS27: Q3 Results Begin: Can We Avoid an Earnings Recession?.NEWS28: Dow up 280 points on gains for UnitedHealth, JPMorgan Chase stocks.NEWS29: Initial Q3 Results Are Better-Than-Expected.NEWS30: For J&J and UnitedHealth, Making Money's Easy for Now.NEWS31: US STOCKS-Wall St rises after upbeat start to earnings season.NEWS32: Bank Earnings Quartet Mostly In Tune, Led By Strength At JPMorgan, Citigroup.NEWS33: Relmada Shares Hit 4-Year High As Depression Drug Aces Midstage Trial.NEWS34: US STOCKS-Wall St headed higher on strong earnings start.NEWS35: UnitedHealth, J.P. Morgan Chase, Johnson & Johnson earnings beats adding combined 119 points to the Dow.NEWS36: UnitedHealth, Johnson & Johnson share gains lead Dow's 135-point climb.NEWS37: For ESG investors, the newest challenge is separating fact from ‘greenwashing’.NEWS38: The Dow Is Rising as Fed Policy, Earnings and Brexit Push Trade Aside.NEWS39: Here's Why You Should Hold on to CONMED (CNMD) Stock for Now.NEWS40: J&J (JNJ) Beats Q3 Earnings & Sales, Shares Rise.NEWS41: Prescription drugs boost drives J&J forecasts higher, shares rise.NEWS42: Johnson & Johnson Trades Higher On Q3 Beat-And-Raise, Despite Legal Entanglements.NEWS43: Dow Jones Futures: Snoozing Stock Market Gets Jolt As 4 Dow Giants Report.NEWS44: J&J boosts full-year outlook but warns of uncertain legal costs.NEWS45: UPDATE 2-Prescription drugs boost drives J&J forecasts higher, shares rise.NEWS46: Johnson & Johnson Earnings, Sales Unexpectedly Rise; JNJ Stock Climbs.NEWS47: Johnson & Johnson shares rise after earnings beat estimates, company raises guidance.NEWS48: Prescription drugs boost drives J&J forecasts higher, shares rise.NEWS49: Johnson & Johnson Reports 2019 Third-Quarter Results.NEWS50: [video]Stocks Rise as Earnings From JPMorgan Chase and UnitedHealth Boost Dow.NEWS51: Johnson & Johnson to Host Earnings Call.NEWS52: Johnson & Johnson Tops Q3 Profit Forecast, Lifts 2019 Guidance: Pharma Surprises.NEWS53: J&J Earnings, Revenue Beat in Q3.

Answer: Rise